These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15169978)

  • 1. Enter Alimta: a new generation antifolate.
    Zhao R; Goldman ID
    Oncologist; 2004; 9(3):242-4. PubMed ID: 15169978
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
    Manegold C
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
    Le Chevalier T
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of pemetrexed in the treatment of colorectal cancer.
    Hochster H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed in the treatment of selected solid tumors.
    Adjei AA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
    [No Abstract]   [Full Text] [Related]  

  • 8. Pemetrexed in bladder, head and neck, and cervical cancers.
    Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed in pancreatic cancer.
    Kindler HL
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future directions in the development of pemetrexed.
    Calvert H; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):54-61. PubMed ID: 12023794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
    Jones RJ; Twelves CJ
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed: single-agent and combination phase I study overview.
    Boyer MJ; Rivory LP; Clarke SJ
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):18-23. PubMed ID: 12571806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed in patients with gastrointestinal carcinoma.
    de Gramont A; Kindler HL
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):42-9. PubMed ID: 12023792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed: a novel antifolate agent enters clinical practice.
    Kut V; Patel JD; Argiris A
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):511-22. PubMed ID: 15270656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.
    Walling J
    Invest New Drugs; 2006 Jan; 24(1):37-77. PubMed ID: 16380836
    [No Abstract]   [Full Text] [Related]  

  • 17. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed: a promising new treatment for breast cancer.
    O'Shaughnessy JA; Gennari A; Conte P
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical development of Alimta (Pemetrexed, LY231514), a multitargeted antifolate.
    Schultz RM
    Prog Drug Res; 2005; 63():275-300. PubMed ID: 16265884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Folate antagonist].
    Morikawa N
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():146-8. PubMed ID: 25831740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.